Technical Optimization of Detection of KRAS, BRAF and NRAS Mutations on Tumor DNA Circulating in Metastatic Colorectal Cancer

NCT02827565 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

OTHER: KRAS, NRAS et BRAF mutation analysis from circulating plasma DNA

Sponsor

Institut de Cancérologie de Lorraine